Blood sugar reducing potentials and heamatological parameters of turmeric (Curcuma longa ) in alloxan-induced diabetic albino rat (Rattus norvegicus ) by Attamah, Gerald Nnamdi et al.
Animal Research International (2021) 18(2): 4104 – 4115                          4104 
ISSN: 1597 – 3115                                                              ARI 2021 18(2): 4104 – 4115 
www.zoo-unn.org 
BLOOD SUGAR REDUCING POTENTIALS AND HEAMATOLOGICAL 
PARAMETERS OF TURMERIC (CURCUMA LONGA) IN ALLOXAN-INDUCED 
DIABETIC ALBINO RAT (RATTUS NORVEGICUS) 
 
1ATTAMAH, Gerald Nnamdi, 1EJIANYA, Esther Chinyere, 2ATTAMAH, Nneka Gertrude, 
3ATTAMAH, Lilian Chinonyelum, 3OGBU, Cynthia Chekwube, 1AKOBE, Nicholas Arome, 
1NWANI, Christopher Didigwu and 1EYO, Joseph Effiong 
1Department of Zoology and Environmental Biology, Faculty of Biological Sciences, University of 
Nigeria, Nsukka, Enugu State, Nigeria. 
2Department of Environmental Management and Control, Centre for Environmental Management and 
Control, University of Nigeria, Enugu Campus, Enugu State, Nigeria. 
3Department of Agricultural Economics, Faculty of Agriculture, University of Nigeria, Nsukka, Enugu 
State, Nigeria. 
 
Corresponding Author: Attamah, G. N. Department of Zoology and Environmental Biology, Faculty 
of Biological Sciences, University of Nigeria, Nsukka, Enugu State, Nigeria. Email: 
gerald.attamah@unn.edu.ng Phone: +234 7030288975 
 




Diabetes mellitus is a chronic metabolic disorder of glucose metabolism characterized by 
elevated blood sugar concentrations due to a loss of insulin-producing pancreatic β-cells 
(type 1 diabetes) or through loss of insulin responsiveness in its target tissues like 
adipose and muscle (type 2 diabetes). This study was undertaken to investigate the 
blood sugar reducing potential of turmeric. The duration of the study was 5 weeks and 
the experimental rats were fed standard rabbit pellet feed and water. Rats were grouped 
into 6 as follows: Group A - normal control, Group B - diabetic and not treated, Group C - 
standard control, and Group D – F were diabetic and treated with different doses of 
turmeric (0, 100, 200 and 400 mg/kg) respectively. Data obtained were analyzed using 
One-way Analysis Variance (ANOVA). Oral administration of methanolic extract of 
turmeric led to a significant reduction in blood glucose levels and normalization of other 
haematological parameters. The extract helped stabilize blood sugar levels and made 
diabetes more manageable. Standard drug (Glibenclamide) effectively treated the 
diabetic condition of the experimental rats. 
 




Diabetes is a disease in which the hallmark 
feature is elevated blood sugar concentrations 
due to a loss of insulin-producing pancreatic β-
cells (type 1 diabetes) or through loss of insulin 
responsiveness in its target tissues like adipose 
and muscle (type 2 diabetes) (Schwartz et al., 
2009). Diabetes affects 5 % of the world 
population and has become the third human 
killer after cancer and cardiovascular disease. 
There is a reservoir of basic information that 
suggests the involvement of oxidative stress in 
the pathogenesis of diabetes mellitus. It is now 
recognized that sustained hyperglycemia in 
diabetic patients, causes protein glycation and 
generates free radicals through auto oxidation 
and polyol pathways (Sharma et al., 2000; 
Ramakrishna and Jailkhani, 2007). High levels of 
free radicals with concurrent decline of 
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antioxidant defense mechanisms may lead to 
the damage of cellular organelles and enzymes 
(Ottaviano et al., 2008). This can culminate in 
increased lipid peroxidation and development of 
insulin resistance, which may consequently 
promote the development of complications of 
diabetes mellitus (Demozay et al., 2008). 
Alloxan is used to induce experimental 
diabetes by selectively destroying pancreatic β-
cell. Alloxan is taken up by pancreatic β-cell and 
subsequently generates reactive oxygen species 
(ROS),which contributes to DNA fragmentation 
and evoke other deleterious changes in the cells 
(Lankin et al., 2004) and cell death (Heikkila et 
al., 1976). Abdul-Hamid and Moustafa (2013) 
reported that alloxan affects directly or 
indirectly on the membrane potential and ion 
channels in β-cells. 
Alloxan causes necrosis of pancreatic β-
cells and induces free radicals which play a 
relevant role in the etiology and 
parthenogenesis of both experimental and 
human diabetes mellitus (Soto et al., 2004). It 
has been suggested that alloxan induces the 
production of hydrogen peroxide (H2O2) and 
some free radicals such as glutathione disulfide 
(GSSG) which produce cellular damage followed 
by cell death. Therefore, alloxan was considered 
adequate for the study of pathology of diabetes 
mellitus (Winterbourn and Munday, 1989). 
Aleeva et al. (2002) reported that alloxan 
decreased the count of insulin producing β-cells, 
but increased the number of glucagon secreting 
α-cells in the pancreas, week 1 of diabetes. 
Numerous experimental studies have 
confirmed the important role of naturally 
occurring phytochemicals in prevention and 
treatment of diabetes, particularly associated 
with oxidative stress (Hegazy et al., 2013; 
Leiherer et al., 2013; Forcados et al., 2017).  
Curcuma longa L. commonly known as 
turmeric has a long history of use in ayurvedic 
medicine for the treatment of inflammatory 
conditions (Jurenka, 2009) and a wide variety of 
diseases including those of the skin, pulmonary 
and gastrointestinal systems, aches, pains, 
wounds, sprains and liver disorders (Aggarwal 
et al., 2007). It acts as a scavenger of oxygen 
free radicals. It can protect haemoglobin from 
oxidation. In in-vitro studies, curcumin can 
significantly inhibit the generation of reactive 
oxygen species (ROS) like superoxide anions, 
H2O2 and nitrite radical generation by activated 
macrophages, which play an important role in 
inflammation (Shukla and Arora, 2003; Ishita et 
al., 2004). Curcumin also lowers the production 
of ROS in-vivo (Bagchi, 2012). It has also been 
used to treat ulcers, parasitic infections, anti-
immune diseases and curing symptoms of colds 
and flus (Siviero et al., 2015). Recent studies 
have shown that curcumin can attenuate cell 
death caused by oxidative stress, indirectly 
through induction and/or activation of 
antioxidant/cytoprotective enzymes, such as 
haeme oxygenase-1 (HO-1) (Lin et al., 2019). 
Due to rapid increase in diabetes cases 
in Nigeria, there is an urgent need for an 
authoritative, practical algorithm for management 
of patients with diabetes mellitus.  
Curcuminoids based extract are well 
studied for their pharmacological and safety 
aspects. Polysaccharide extract of C. longa is 
gaining importance since it showed to have 
various pharmacological activities, which include 
antidiabetic, antitumor, antidepressant, antioxidant, 
antimicrobial/antifertility, hepatoprotective and 
immunomodulatory properties (Calabrese et al., 
2003; Mohankumar and McFarlane 2011). This 
experimental research is geared to verifying the 
antidiabetic effect of C. longa extract in alloxan-
induced diabetic albino rat by examining the 
blood sugar levels as well as changes in the 
haematological parameters. 
 
MATERIALS AND METHODS 
 
Plant Materials: Fresh rhizomes were 
procured from Ogbuette Market, Nsukka LGA, 
Enugu State. The plant and rhizome were 
identified (Zimdahl, 2018), and authenticated by 
a plant taxonomist in the Department of Plant 
Science and Biotechnology, University of 
Nigeria, Nsukka, where voucher specimen (No: 
PSB-085) was deposited in their herbarium for 
reference purposes. The rhizomes were 
carefully selected and washed off of dirt. The 
wet weight of the turmeric was weighed (wet 
weight = 4.5 kg). The rhizomes were cut 
longitudinally shredded and dried at room 
temperature until a constant weight was 
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maintained. The dry shreds were grounded into 
powder and weighed (dry weight = 0.8 kg). 
  
Turmeric Methanolic Extract: About 0.8 kg 
of the dry powder of turmeric was placed in a 
closed vessel and macerated in 800 ml of 
absolute methanol. The system was allowed to 
stand for 72 hours with intermittent shaking. 
The mixture was filtered using Muslin sieve and 
then with Whatmann filters paper number 42. 
The filtrate was allowed to dry for 3 days over 
water bath set at 50oC. Methanol was used as 
the solvent for extraction because it has a 
clearer spectrum for extraction and it 
evaporates easily making the drying process 
faster. 
 
Experimental Animal: Fourty five (45) adult 
male albino rats of similar age and weighing 150 
± 2.89 g obtained from Animal Breeding and 
Genetic Laboratory, Department of Zoology and 
Environmental Biology, University of Nigeria 
were used for the experiment. They were given 
clean water and a standard pellet diet (Specialty 
Feeds: 19 % crude protein and 14.3 Mj/Kg 
metabolizable energy) twice daily. Ethical 
approval for the study (UNN-FBS-2020-081) was 
obtained from the Faculty of Biological Science 
Ethical Committee. All investigations were 
conducted in accordance with the accepted 
principles for laboratory animal use and care 
(NRC, 2011). 
 
Acute Toxicity Test: Three groups of healthy 
albino rats with average weight of 150 ± 2.89 g 
were used to do toxicity test using OECD 
method (OECD, 2012). Three animals each were 
treated with the crude extract of turmeric (300, 
900 and 2000 mg/kg) orally. The animals were 
observed after 24 hour for signs of toxicity and 
percentage mortality in each group was 
recorded. The LD50 for oral routes was 
determined by plotting log dose against 
percentage death but the experiment did not 
reveal any form of toxicity in the rats. From the 
experiment carried out, the rats did not die at 
any of these concentrations 
 
Phytochemical Assay of Turmeric: The 
assay for phytochemical components of turmeric 
was adopted from Chanda and Ramachandra 
(2019). 
 
Alloxan Induction: The weight of the rats 
using electronic scale and their blood sugar level 
using a glucometer were measured after an 
overnight fast. The experimental rats were 
grouped into 6 with rats in each group. Groups 
1 and 2 served as normal and diabetic control 
respectively, so 5 groups of rats were made 
diabetic with a single intraperitoneal injection of 
120 mg alloxan/kg per body weight. Rats were 
identified as diabetic on the basis of blood 
glucose levels ranging above 180 mg/dl after 3 
days of induction. The rats were then regrouped 
according to their diabetic ranges. 
 
Preparation of the Dosage: 0.5 g of the 
methanolic extract of C. longa was weighed and 
dissolved in 6 ml of 30 % of tween-80 solution, 
and a required dose of 100, 200 and 400 mg/kg 
body weight were calculated from the effective 
dose. 
 
Experimental Design and Administration 
of Turmeric Extract to Diabetic Rat: The 
experiment was laid out in a complete 
randomized design of six treatment groups, 
replicated thrice with each replicate having two 
rats. Methanolic extract of turmeric was 
administered orally to the animals. Group 1 
received a standard rat pellet meal and Tween 
80 daily, Group 2 served as diabetic control, 
Group 3 received a dose of 100 mg/kg body 
weight of turmeric extract, Group 4 received a 
dose of 200 mg/kg body weight of turmeric 
extract, Group 5 received a dose of 400 mg/kg 
body weight of turmeric extract, Group 6 
diabetic rats were treated with standard drug 
(Glibenclamide) at 10 mg/kg body weight. The 
sub-lethal dosages used were arrived at by 
dividing the LD50 (2000 mg/kg) by a factor (20) 
to have the initial dose that was subsequently 
increased by doubling the value.  
 
Collection of Blood: Blood samples were 
collected from one rat per replicate for 
haematological studies. The blood samples were 
taken every week till the end of the experiment. 
Baseline blood analyses were done before the 
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administration of the extract commenced. The 
blood was collected via the orbital sinus using a 
capillary tube and was put in a clean ethylene 
diamine tetra acetic (EDTA) bottles to prevent 
coagulation (Banfi et al., 2007). The blood for 
glucose concentration determination using 
glucometer method (Togashi et al., 2016) was 
not exposed to EDTA. 
 
Blood Glucose: Blood sample for initial glucose 
determination just before induction were 
obtained from the tip of tail of the rats in the 
groups. The tip of the tail was cut and a little 
pressure applied to allow for blood flow. A drop 
of blood was placed on the sensitive part of the 
glucometer strip (already fixed) and the reading 
shown on the glucometer was taken. 
Subsequent blood glucose determination was 





Packed Cell Volume (PCV): PCV volume was 
determined by the microhaematocrit method. 
Blood sample was placed in a microcapillary 
tube, sealed at one end with soap bar and 
centrifuged at 10000 rpm for 5 minutes using a 
haematocritcentrifuge. After centrifugation, the 
PCV were read using a microhaematocrit reader 
(Sood, 2006). 
 
Haemoglobin Concentration: About 4 ml of 
haemoglobin reagent (Drapkin’s solution) was 
put in test tube, and 0.02 ml of the blood 
sample was added and mixed thoroughly. The 
mixture was allowed to react for 10 minutes and 
the absorbance were read at 540 nm 
wavelength against a reagent blank in a 
spectrophotometer. Standards were prepared as 
above without blood sample and also read at 
540 nm. The haemoglobin concentration of the 
blood samples was obtained by multiplying the 
absorbance of the sample with a calibration 
factor derived from the absorbance and 
concentration of the standard (Sood, 2006). 
 
Red Blood Cell Count: The red blood cell 
count was determined using haemocytometer 
according to the method of Sood (2006). About 
0.02 ml of the blood sample was added to 3.95 
ml of NaCl in a clean test tube to make a 
dilution of the blood sample. The diluted blood 
sample were loaded onto a Neubauer counting 
chamber and all red blood cells in all the groups 
of 16 small squares in the central area of the 
Neubauer chamber were counted using a light 
microscope at x 40 objectives. The number of 
cells counted for each sample was multiplied by 
10,000 to obtain the red blood cells count per 
microliter of blood. The derivatives of the RBC 
were obtained following Baker et al. (2001). 
 
White Blood Cell Count: 0.02ml of blood 
sample was pipetted into a small test tube 
containing 0.38 ml of white blood cell diluting 
fluid (Turk’s solution) to make 1:20 dilution of 
the blood sample. The diluted sample were 
loaded onto the Neubauer counting chamber 
and all cells on the four-corner square counted 
using a light microscope at x10 objective, the 
number of cells counted for each blood sample 
was multiplied by 50 to obtain the total blood 
cell count per microliter of blood (Sood, 2006). 
 
Statistical Analysis: Data were analyzed using 
one-way analysis of variance (ANOVA) and 
Duncan multiple range test to separate the 
group means. P<0.05 was considered 
significant. The results were reported as means 
±standard error of mean (S.E.). All analyses 
were done using Statistical Package for Social 
Sciences (SPSS), Version 21, IBM Corporation, 




Toxicity and Phytochemical Content of 
Turmeric: No mortality and adverse effects 
were observed even at the highest dose (2000 
mg/Kg) of the turmeric. The phytochemical 
components of turmeric leaves shows the 
presence of carbohydrates, proteins, alkaloids, 
glycosides, terpenes, steroids, flavonoids, 
tannins, saponins and phenols (Chanda and 
Ramachandra, 2019). 
 
Effects of Turmeric on the Glucose Levels 
of Diabetic Rat: The initial glucose levels of 
the rats recorded significantly highest (p<0.05) 
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values in 400 mg/kg turmeric treated group 
(97.33 ± 86.06 mg/dL), followed by the diabetic 
not treated group (83.00 ± 3.75 mg/dL), while 
the standard control had the lowest mean value 
of 68.50 ± 2.79 mg/dL (Table 1). The post 
diabetic induced glucose level of the standard 
control (474.00 ± 9.59 mg/dL) was the highest, 
while the normal control had the lowest (83.50 
± 1.20 mg/dL). At Week 1, the glucose level of 
the diabetic not treated (490.00 ± 42.78 mg/dL) 
was significantly highest (p<0.05), followed by 
the standard control (437.00 ± 415.68 mg/dL), 
while the normal control had the lowest (85.33 
± 0.92 mg/dL) glucose levels. The glucose 
levels of the turmeric treated groups were lower 
than the standard control and diabetic not 
treated groups, but higher than the value 
observed in the normal control group. The 
diabetic not treated group and the normal 
control also recorded the highest and the lowest 
mean value of glucose 335.00 ± 324.65 mg/dL 
and 86.50 ± 84.78 mg/dL respectively at Week 
2. At week 3, the diabetic not treated 
maintained the highest mean value of glucose 
(217.00 ± 4.44 mg/dL), followed by the 100 
mg/kg turmeric dosed group (203.67 ± 3.39 
mg/dL), while the least was recorded in normal 
control (84.83 ± 1.05 mg/dL), with significant 
differences (p<0.05). 
The normal control showed no 
significant (p>0.05) difference in the mean 
glucose levels across the duration. The standard 
control and the groups treated with 100 and 
400 mg/kg of turmeric had significant (p<0.05) 
duration dependent decrease in glucose from 
post induction to week 3 respectively. The 
diabetic not treated group also recorded a 
significant (p<0.05) duration dependent 
decrease in glucose levels from week 1 to 3 
(Table 1). 
 
Effects of Turmeric on the Packed Cell 
Volume of Diabetic Rat: The mean PCV of 
the normal (51.33 ± 0.88 %) and standard 
(46.33 ± 1.20 %) controls recorded significantly 
highest (p<0.05) values when compared with 
the other groups at Week 1 (Table 2). The PCV 
result of the induced not treated was the lowest 
(26.00 ± 1.73 %), while that of the turmeric 
treated groups did not differ significantly 
(p>0.05) from each other. At week 2, the 
normal control recorded the highest PCV of 
50.00 ± 1.15 %, while the standard control had 
the least (24.50 ± 0.29 %). The turmeric 
treated groups had significant (p<0.05) dose-
dependent decrease in PCV values at Week 2. 
At Week 3, the normal control and induced not 
treated group recorded the highest (51.33 ± 
1.33 %) and the lowest (32.33 ± 1.20 %) mean 
PCV values respectively with significant 
differences (p<0.05). 
The PCV values of the normal control 
was not significantly different (p>0.05) across 
the week. The weekly comparison of the PCV 
results showed a significant decrease and 
increase (p<0.05) in PCV at Weeks 2 and 3 
respectively in standard control, 200 and 400 
mg/kg turmeric treated groups. The induced not 
treated and 100 mg/kg turmeric treated group 
showed a significant increase and decrease 
(p<0.05) in PCV at Weeks 2 and 3 respectively 
(Table 2). 
 
Effects of Turmeric on the Haemoglobin 
Levels of Diabetic Rat: The normal and 
standard controls recorded significantly higher 
(p<0.05) mean Hb values compared with the 
other treatment groups at week 1 (Table 3). 
The diabetic untreated group had the lowest 
mean Hb value (6.54 ± 0.169 g/dL), followed by 
the group treated with 100 mg/kg of turmeric 
(8.46 ± 0.64 g/dL) and 200 mg/kg (8.46 ± 0.22 
g/dL) that did not differ significantly (p>0.05) 
from each other. At Week 2, the mean of Hb in 
normal control did not differ significantly 
(p>0.05) from the groups treated with 100, 200 
and 400 mg/kg of turmeric. The normal control 
had the highest mean Hb (10.72 ± 0.29 g/dL), 
followed by the standard control (9.73 ± 0.28 
g/dL), while the diabetic not treated had the 
lowest Hb value (4.71 ± 0.39g/dL). The mean 
Hb concentrations of the turmeric treated 
groups were dose-dependent at Week 3. 
Comparing the Hb values across the 
weeks revealed no significant difference 
(p>0.05) in the mean Hb value of rat in the 
normal control.  
4108 
Attamah et al.                                                                                                                         4105 
Animal Research International (2021) 18(2): 4104 – 4115 
Table 1: Effects of methanolic extract of turmeric rhizome on the glucose levels (mg/dl) of diabetic albino rat 
Treatment groups Concentration 
(mg/kg) 
Glucose level (mg/dl) 
 Initial Post induction Week 1  Week 2 Week 3 
Normal control - 82.83 ± 1.51b1 83.50 ± 1.20a1 85.33 ± 0.92a1 86.50 ± 84.78a1 84.83 ± 1.05a1 
Standard control 
(Glibenclamide) 
10 68.50 ± 2.79a1 474.00 ± 9.59e4 437.00 ± 415.68d4 263.00 ± 228.51c3 147.00 ± 5.79b2 
Diabetic untreated (Tween 80) 0 83.00 ± 3.75b1 408.50 ± 7.48d34 490.00 ± 42.78d4 335.00 ± 324.65e3 217.00 ± 4.44d2 
Diabetic treated with turmeric 100 76.50 ± 67.57ab1 369.00 ± 12.90cd4 324.67 ± 3.31c4 291.50 ± 10.96d3 203.67 ± 3.39d2 
Diabetic treated with turmeric 200 73.33 ± 63.19ab1 252.83 ± 13.83b4 206.67 ± 3.10b3 232.00 ± 5.37b4 178.00 ± 1.46c2 
Diabetic treated with turmeric 400 97.33 ± 86.06c1 335.33 ± 40.64c5 299.67 ± 28.81c4 242.50 ± 14.98bc3 181.33 ± 10.05c2 
Mean values with different alphabets as superscripts in a column differ significantly (p<0.05); Mean values with different numbers as superscripts in a row differ significantly (p<0.05) 
 
Table 2: Effects of methanolic extract of turmeric rhizome on the packed cell volume levels of diabetic albino rat 
Treatment groups Concentration  
(mg/kg) 
Packed cell volume (%) 
Week 1 Week 2 Week 3 
Normal control - 51.33 ± 0.88c1 50.00 ± 1.15e1 51.33 ± 1.33c1 
Standard control (Glibenclamide) 10 46.33 ± 1.20bc2 24.50 ± 0.29a1 46.67 ± 1.45b2 
Diabetic not treated (Tween 80) 0 26.00 ± 1.73a1 43.50 ± 0.29c3 32.33 ± 1.20a2 
Diabetic treated with turmeric 100 41.00 ± 1.15b1 47.00 ± 0.58d3 44.33 ± 0.88b2 
Diabetic treated with turmeric 200 41.00 ± 1.00b1 41.50 ± 0.87bc1 45.67 ± 1.20b2 
Diabetic treated with turmeric 400 44.00 ± 3.06b2 41.00 ± 0.58b1 45.67 ± 0.33b2 
Mean values with different alphabets as superscripts in a column differ significantly (p<0.05); Mean values with different numbers as superscripts in a row differ significantly (p<0.05) 
 
Table 3: Effects of methanolic extract of turmeric rhizome on the haemoglobin levels of diabetic albino rat 
Treatment groups Concentration  
(mg/kg) 
Haemoglobin level (g/dl) 
Week 1 Week 2 Week 3 
Normal control - 11.40 ±0.20d2 9.71 ±0.29d1 10.72 ±0.29b12 
Standard control (Glibenclamide) 10 10.83 ±0.30d2 7.05 ±0.45a1 9.73 ±0.28cb2 
Diabetic not treated (Tween 80) 0 6.54 ±0.17a2 7.42 ±0.07bc2 4.71 ±0.39a1 
Diabetic treated with turmeric 100 8.46 ±0.64b1 8.50 ±1.53c1 7.32 ±0.43b1 
Diabetic treated with turmeric 200 8.46 ±0.64b1 9.05 ±0.22bc1 8.87 ±0.50b1 
Diabetic treated with turmeric 400 9.63 ±0.35bc1 9.09 ±0.26ab1 9.25 ±0.68c1 
Mean values with different alphabets as superscripts in a column differ significantly (p<0.05); Mean values with different numbers as superscripts in a row differ significantly (p<0.05)
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Table 4: Effects of methanolic extract of turmeric rhizome on the white blood cell levels 
of diabetic albino rats 
Treatment groups Concentration 
(mg/kg) 
White blood cell counts (x 109/L) 
Week 1 Week 2 Week 3 
Normal control - 6433.33 ± 317.98a2 6700.00 ± 57.73a3 5866.67 ± 176.38a1 
Standard control 
(Glibenclamide) 
10 7100.00 ± 173.20ab1 120000.00 ± 346.41e2 6300.00 ± 208.17ab1 
Diabetic not treated 
(Tween 80) 
0 9600.00 ± 416.33d1 9500.00 ± 173.21d1 11000.00 ± 416.33e2 
Diabetic treated with 
turmeric 
100 8866.67 ± 405.51cd2 7350.00 ± 144.34b1 8466.67 ± 545.69d2 
Diabetic treated with 
turmeric 
200 8166.67 ± 185.59bc2 8600.00 ± 115.47c2 7300.00 ± 264.58bc1 
Diabetic treated with 
turmeric 
400 7966.67 ± 425.57bc1 9600.00 ± 115.47d2 7733.33 ±176.38cb1 
Mean values with different alphabets as superscripts in a column differ significantly (p<0.05); Mean values with different 




Turmeric is a well-known condiment, which is 
used in our daily diet and has many medicinal 
properties (Santoshkumar et al., 2013).The 
research aimed at evaluating the anti-diabetic 
effect of turmeric which is rich in active ingredient 
- curcumin.  
Investigations of acute toxicity study 
revealed no signs and symptoms or toxicity or 
mortality in any of the animals even at a very high 
dose. Consequently, the present study indicated 
that turmeric has no toxic effects in rats. This 
result was in agreement with the study of 
Aggarwal et al. (2016) on of the non-toxicity of 
curcuminoid-essential oil complex (a bioavailable 
turmeric formulation) in rats. Therefore, following 
investigations of acute toxicity, turmeric was safe, 
non-toxic pharmacological formulation. 
Turmeric contains a wide variety of 
phytochemicals, including curcumin, turmerin, 
demethoxycurcumin, bisdemethoxycurcumin, 
tetrahydrocurcumin, eugenol, triethylcurcumin, 
zingiberene, curcumenol, curcumol, turmerones 
and turmeronols. Among these phytochemicals, 
the most active component of turmeric is 
curcumin which gives a yellow color to turmeric 
and responsible for most of the therapeutic effects 
(Adinew, 2012). Other phytochemical components 
of turmeric are carbohydrates, proteins, alkaloids, 
tannins, saponins, glycosides, terpenes, steroids, 




Research carried out by Santoshkumar et al. 
(2013) showed that turmeric extract 300 mg/kg 
significantly reduced the blood glucose levels in 
diabetic rats from 7th day onwards. But 500 mg/kg 
had more efficient action, as reduction in blood 
glucose levels was statistically highly significant. 
This experiment showed significant dose-
dependent decrease in blood sugar in turmeric 
treated groups. Glibenclamide, a standard anti-
diabetic drug, reduced blood glucose by a highly 
significant level. The possible mechanism of the 
effect of curcumin on glycaemia in diabetes 
models may be because curcumin could attenuate 
tumor necrosis factor-α (TNF-α) levels (El-Azab et 
al., 2011). 
There are various mechanisms for anti-
diabetic effect of curcumin. One of the most 
fundamental of these mechanisms is that 
improvement in beta-cells function through its 
anti-inflammatory and anti-oxidant properties 
(Rivera-Mancía et al., 2015). In addition curcumin 
reduces fasting blood glucose by increasing 
peroxisome proliferator-activated receptor (PPAR) 
activity, inhibits hyperglycemic, increases 
glycolysis, inhibits liver gluconeogenesis, 
stimulations secretion insulin from pancreas, 
provokes glucose uptake by increasing gene 
expression of GLUT4, GLUT2 and GLUT3, 
suppresses liver production through improvement 
AMP kinase activation and inhibits glucose 6 
phosphate kinase (Hodaei et al., 2019). On the 
other hand curcumin increases the expression of 
adiponectin genes and thus leads to raising insulin 
sensitivity. 
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In this study, oral administration of 
turmeric extract caused significant changes in PCV 
of rats comparatively throughout the weeks of 
treatment. PCV is the measurement of the 
proportion of blood that is made up of cells. The 
value is expressed as a percentage or fraction of 
cells in the blood. For example, a PCV of 40 % 
means that there are 40 milliliters of cells in 100 
milliliters of blood (Fairbanks and Tefferi, 2000). 
This experiment showed that PCV decreased 
significantly in diabetic and untreated rat as well 
as 100 mg/kg turmeric treated rat, while it 
increased with higher concentration of turmeric 
extract (200 and 400 mg/kg) and rats treated with 
standard drug (Glibenclamide). A research carried 
out by Jaman et al. (2018) showed that PCV 
decreased significantly in diabetic patients (HbA1c 
≥ 75) when compared with non-diabetic patients 
(HbA1c ≤ 6.5). The decreased value of diabetic 
patient may be due to the dehydration and 
accumulation of protein. 
Haemoglobin is known as a protein in red 
blood cells that helps store and transport oxygen. 
The turmeric treated rat groups had considerable 
low Hb when compared to the normal and 
standard group which showed alterations across 
the research period. The diabetic not treated had 
the lowest Hb value throughout the research 
period. This supports the fact that diabetic 
nephropathy and diabetic retinopathy result in 
increased susceptibility to low haemoglobin levels 
(Ranil et al., 2010). 
Alloxan exposure resulted in slight 
decreases in RBC and HB levels all of which may 
lead to anaemia. Reduction in the RBC counts may 
be attributed to hyperactivity of the bone marrow, 
leading to the production of red blood cells with 
impaired integrity which were easily destructed in 
the circulation or also termed as atrophied 
erythrocytes (Hossen et al., 2017). Our findings 
suggest that the decrease in RBC counts (i.e. 
microcytic hypochromic anaemia) occur due to 
excessive damage to the erythrocytes or inhibition 
of erythrocyte formation as also reported by 
Elsharkawy et al. (2013). However, administration 
of turmeric increased the RBC and HB levels, 
indicating immune stimulatory activity of the 
extract (Hossen et al., 2017) rendering turmeric as 
a potential alternative armamentarium against 
anaemia. 
This research also showed decrease in 
RBC of the diabetic not treated rats and in 
turmeric treated rat relative to rats in the normal 
and standard group. There was significant 
increase in all groups at week 3, this could be due 
to continual production of RBC in the bone 
marrow.  The increase in the RBC count of rats 
with increased concentration of turmeric may be 
associated with the effects of turmeric bioactive 
compounds on improving antioxidant status of the 
rats (Amalraj et al., 2017). Tuntipopipat et al. 
(2009) noted a case of a possible human iron 
deficiency due to the absorption of iron in the gut 
due turmeric. While causality cannot be readily 
determined, the patient’s haemoglobin, iron and 
ferratin were reduced after turmeric was started 
and went back to normal after it was stopped. 
Administration of turmeric to the 3 treated groups 
possibly contributed to low Hb levels. 
White blood cell count was highest in 
infected untreated group, less in turmeric treated 
groups and least in the standard and normal 
group. According Srinivasan et al. (2003), glucose 
causes significant production of interleukin 8, a 
potent chemo-attractant that may be responsible 
for recruitment of neutrophils by human 
endothelia cells. That is to say that hyperglycemia 
causes high level of white blood cells. High white 
blood cell count may indicate that the immune 
system is working to destroy the infection, it may 
also be a sign of physical or emotional stress as in 
the case of diabetes oxidative stress. 
 
Conclusion:  Turmeric is a promising medicinal 
plant which can be used as an adjunct to drug and 
diet therapy for the management of diabetes 
mellitus. Curcumin is a potent antioxidant that can 
neutralize free radicals due to its chemical 
composition and structure. Curcumin supplements 
should be taken at early stages of diabetes to 
prevent further oxidative damage and production 
of reactive oxygen species associated with 
diabetes. Daily dose of 200 to 400 mg of turmeric 
is recommended in preparing diet for diabetic 
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